Massimo Aglietta

24.5k citations
397 papers · 14.5k · 2 hit papers · h-index 58

Impact in

  • Oncology top 0.1%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • CAR-T cell therapy research
    • HER2/EGFR in Cancer Research
  • Hematology top 0.2%
    • Hematopoietic Stem Cell Transplantation

Papers in

    • HER2/EGFR in Cancer Research 47
    • CAR-T cell therapy research 36
    • Colorectal Cancer Treatments and Studies 33
    • Cancer Treatment and Pharmacology 32
    • Cancer Immunotherapy and Biomarkers 27
    • Hematopoietic Stem Cell Transplantation 45

Massimo Aglietta

389 papers receiving 14.2k citations

Massimo Aglietta's Hit Papers

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer 2018 · 1.4k citations
1.4k0+12+24Years since publication4008001.2k

Peers

Massimo Aglietta
Comparison fields: 5 of 138
  • Oncology 7.1k
  • Hematology 2.4k
  • Immunology 3.0k
  • Cancer Research 1.9k
  • Genetics 1.3k
Replace Hans Kreipe with:
Hans Kreipe Germany
Mitsune Tanimoto Japan
Karen R. Cleary United States
Janice P. Dutcher United States
Franco Dammacco Italy
Svetomir N. Markovic United States
Jonathan Said United States
Kim Margolin United States
Andrew Arnold United States
Ronit Simantov United States
Massimo Aglietta relative to Hans Kreipe Germany Hans Kreipe's profile →
Citations per field
00.5×1.5×2.4×
Hans Kreipe · 1×
Citations per year

Countries citing papers authored by Massimo Aglietta

Since Specialization
Citations

This map shows the geographic impact of Massimo Aglietta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Aglietta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Aglietta more than expected).

Fields of papers citing papers by Massimo Aglietta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Aglietta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Aglietta. The network helps show where Massimo Aglietta may publish in the future.

Co-authors

The 25 scholars most cited alongside Massimo Aglietta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Massimo Aglietta Line = papers co-authored together Massimo Aglietta links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 397 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Hit paper breakdown →
20181429
2
Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate
Hit paper breakdown →
1989537
3 2007479
4 1983366
5 1997363
6 2007320
7 2011279
8 2014260
9 1999256
10 2005253
11 1986194
12
Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.
1981194
13 2012192
14 2004179
15 2014169
16 2019165
17 1987151
18 2009146
19 2010143
20 1986142

About Massimo Aglietta

Massimo Aglietta is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Immunology and Surgery, having authored 397 papers that have together received 14.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (47 papers), Hematopoietic Stem Cell Transplantation (45 papers), CAR-T cell therapy research (36 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers), Colorectal Cancer Treatments and Studies (33 papers), Cancer Treatment and Pharmacology (32 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Immune Cell Function and Interaction (27 papers). The work is most often cited by research in Oncology (7.1k citations), Hematology (2.4k citations), Immunology (3.0k citations), Cancer Research (1.9k citations) and Genetics (1.3k citations). Massimo Aglietta has collaborated with scholars based in Italy, United States and France. Frequent co-authors include F Sanavio, Filippo Montemurro, Wanda Piacibello, Giorgio Valabrega, Federico Bussolino, Franca Fagioli, Loretta Gammaitoni, Dario Sangiolo, Giovanni Camussi and Giuliana Cavalloni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, Cancers and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact